- All
- #InspiredByLife
- Bioeconomy
- Biosimilars
- BREXIT
- Cell & Gene Therapies
- Circular Economy
- Climate Change
- COVID-19
- Factsheet
- Genome editing
- HEALTHCARE BIOTECH
- INDUSTRIAL BIOTECH
- Innovation
- Intellectual Property
- Interview
- Jobs & Growth
- NATIONAL ASSOCIATIONS
- News
- Other
- Patient Bio-Forum
- Position Paper
- Press release
- Public Procurement
- Regulatory Efficiency
- Report
- SME
- SME Platform
- WHAT IF
- White paper
July 29, 2021
July 22, 2021
June 29, 2021
EuropaBio is pleased to announce that EV Biotech has joined the organization as an Associate Member.
June 23, 2021
EuropaBio sat down with new Member Technology Park Ljubljana, to find out about their journey from creation in 1994.
June 23, 2021
EuropaBio is pleased to announce that Technology Park Ljubljana has joined the organization as part of the National Associations Council.
June 14, 2021
EuropaBio is delighted to announce that Novartis has joined EuropaBio’s 25th Anniversary Celebration Programme as a Sponsor.
June 9, 2021
EuropaBio sat down with new Member Lallemand, to find out what fires them up for the future of industrial biotechnology.
May 20, 2021
The COVID-19 pandemic has been a catalyst for change which has led us to revisit the way we conduct clinical trials.
May 19, 2021
EFIB 2021 ’Delivering the EU Green Deal: Industrial biotechnology into business’: Registration is Open
May 18, 2021
EuropaBio sat down with new Member Lallemand, to find out what fires them up for the future of industrial biotechnology.
May 18, 2021
EuropaBio is pleased to announce that Lallemand has joined the organization as a corporate member.
May 7, 2021
IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge
2021_05_H_PR_Waiver of Intellectual Property Rights for COVID-19 Vaccines – EuropaBio’s Position
May 4, 2021
EuropaBio sat down with new corporate member Kaffe Bueno, to find out more about the future of coffee.
